Virus Capture Kits
Get more from your samples and get it faster. Knowing a virus is present in a sample and not being able to detect it is frustrating. Use Nanotrap® Magnetic Virus Particles to concentrate viruses rapidly from complex biological matrices in order to have high quality input material for your downstream analytical methods.
Nanotrap® Magnetic Virus Particles capture and concentrate the following respiratory viruses: influenza A H1N1 (1), Influenza A H3N2 (1), influenza B (1), respiratory syncytial virus A2001/3-12 strain (1), coronavirus strain 229E (1), coronavirus strain OC43 (2), and SARS-CoV-2 (3)(4).
Methods developed for clinical swab samples, saliva, and wastewater. (3)(4)(5)(7)(8)
Reduce clinical sample processing time by 2- to 3-fold by eliminating commercial extraction kit.
Enables an automated method for concentrating and processing virus from 24 wastewater samples in 40 minutes, reducing processing time by at least 20-fold, as compared to other methods. (8)
Enables pooled patient sample testing with methods developed for sample volumes up to 10 mL. (4)(6)
Eliminate false negatives. Nanotrap particles enabled the identification of SARS-CoV-2 RNA in 9 out of 32 diagnostic remnant samples that had previously tested negative for the virus. (4)
Increase assay sensitivity by capturing and concentrating low abundance viruses. Nanotrap particles improved the real-time RT-PCR signal in low viral load diagnostic remnant samples by an average of 3.1 Ct values. (4)
Successfully utilized in RT-PCR assays with FDA Emergency Used Authorization for COVID-19. (9)
Nanotrap® particles utilize affinity capture and enrichment to attract and bind low abundance viruses. Nanotrap® particles do not utilize antibodies or other biomolecules as affinity molecules.
Incorporating the Nanotrap® technology into your workflow is simple. Reduce your sample real-time RT-PCR sample processing time by 2-3 fold by eliminating a commercial extraction kit altogether.